Skip to main content
Premium Trial:

Request an Annual Quote

GigaGen Gets More Than $1M in Grants to Develop Cell-Seq Technology

NEW YORK (GenomeWeb News) – Genetics-based diagnostic company GigaGen today said that it has received four grants totaling more than $1 million to develop and validate its Cell-Seq technology to aid in the prediction of immune flares in transplant recipients and autoimmune patients.

The grants are from the National Institutes of Health and the National Science Foundation. Three will go toward the development, validation, and characterization of the San Francisco-based company's Cell-Seq technology, which measures genotype and expression of dozens of target genes across millions of single cells, GigaGen said. The technology enables massively parallel single-cell genetic analysis.

The fourth grant will be used to develop web-based tools for processing, analyzing, and visualizing Cell-Seq data.

Using microfluidics and next-generation sequencing, the Cell-Seq technology will be the first to empower physicians to monitor a patient's disease-specific immune activity and provide care on a personalized basis to prevent and treat immune flares, GigaGen said, adding it expects to commercialize its first clinical test in 2013 at leading academic medical centers.

Earlier this year GigaGen and Dolomite announced a deal to co-develop a droplet merger chip for massively parallel single cell genetic analysis.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.